TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 14,186 | 16,952 | 18,753 |
Financial expenses | 209 | 41 | 57 |
Earnings before taxes | 557 | 765 | 846 |
EBITDA | 588 | 812 | 884 |
Total assets | 11,884 | 20,421 | 10,148 |
Current assets | 11,171 | 18,941 | 8,632 |
Current liabilities | 7,356 | 9,566 | 5,250 |
Equity capital | 2,679 | 2,492 | 1,944 |
- share capital | 90 | 98 | 100 |
Employees (average) | 18 | 31 | 35 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 22.5% | 12.2% | 19.2% |
Turnover per employee | 788 | 547 | 536 |
Profit as a percentage of turnover | 3.9% | 4.5% | 4.5% |
Return on assets (ROA) | 6.4% | 3.9% | 8.9% |
Current ratio | 151.9% | 198.0% | 164.4% |
Return on equity (ROE) | 20.8% | 30.7% | 43.5% |
Change turnover | -1,393 | -1,454 | -1,130 |
Change turnover % | -9% | -8% | -6% |
Chg. No. of employees | -13 | -4 | 1 |
Chg. No. of employees % | -42% | -11% | 3% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.